tirzepatide surmount trials SURMOUNT-1 Trial SURMOUNT-1 Trial - Cardionerds Twitter

Oral Semaglutide GLP-1 medication for weight loss without injections

Semaglutide injection users typically lose 1022% of their starting body weight over 68 weeks, though results vary based on genetics, lifestyle, and dosage progression

Follow for more updates just like this | 17 comments on LinkedIn

Flu strains may vary from area to area, so if you are exposed to a strain of the flu that is not the same strain as the one your flu shot protects against, you may still get the flu

The Wegovy pill (oral semaglutide) is now approved in the UAE

And when youre on a GLP-1 receptor agonist, your nutritional strategy is more important than ever